640 related articles for article (PubMed ID: 25897794)
21. Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: a crucial role for Krüppel-like factor 2.
van Tits LJ; Stienstra R; van Lent PL; Netea MG; Joosten LA; Stalenhoef AF
Atherosclerosis; 2011 Feb; 214(2):345-9. PubMed ID: 21167486
[TBL] [Abstract][Full Text] [Related]
22. Cytokine response to lipoprotein lipid loading in human monocyte-derived macrophages.
Persson J; Nilsson J; Lindholm MW
Lipids Health Dis; 2006 Jun; 5():17. PubMed ID: 16800873
[TBL] [Abstract][Full Text] [Related]
23. Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by toll-like receptor agonists.
Kazemi MR; McDonald CM; Shigenaga JK; Grunfeld C; Feingold KR
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1220-4. PubMed ID: 15705927
[TBL] [Abstract][Full Text] [Related]
24. Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient Mice.
Du F; Gesang Q; Cao J; Qian M; Ma L; Wu D; Yu H
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869741
[TBL] [Abstract][Full Text] [Related]
25. FABP4 inhibitor BMS309403 decreases saturated-fatty-acid-induced endoplasmic reticulum stress-associated inflammation in skeletal muscle by reducing p38 MAPK activation.
Bosquet A; Girona J; Guaita-Esteruelas S; Heras M; Saavedra-García P; Martínez-Micaelo N; Masana L; Rodríguez-Calvo R
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jun; 1863(6):604-613. PubMed ID: 29550588
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice.
Xie W; Li L; Zhang M; Cheng HP; Gong D; Lv YC; Yao F; He PP; Ouyang XP; Lan G; Liu D; Zhao ZW; Tan YL; Zheng XL; Yin WD; Tang CK
PLoS One; 2016; 11(6):e0157085. PubMed ID: 27257686
[TBL] [Abstract][Full Text] [Related]
27. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects.
Westerbacka J; Kolak M; Kiviluoto T; Arkkila P; Sirén J; Hamsten A; Fisher RM; Yki-Järvinen H
Diabetes; 2007 Nov; 56(11):2759-65. PubMed ID: 17704301
[TBL] [Abstract][Full Text] [Related]
28. Phospholipase A2-modified low-density lipoprotein activates macrophage peroxisome proliferator-activated receptors.
Namgaladze D; Morbitzer D; von Knethen A; Brüne B
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):313-20. PubMed ID: 19948841
[TBL] [Abstract][Full Text] [Related]
29. PPARgamma phosphorylation mediated by JNK MAPK: a potential role in macrophage-derived foam cell formation.
Yin R; Dong YG; Li HL
Acta Pharmacol Sin; 2006 Sep; 27(9):1146-52. PubMed ID: 16923334
[TBL] [Abstract][Full Text] [Related]
30. IgE Contributes to Atherosclerosis and Obesity by Affecting Macrophage Polarization, Macrophage Protein Network, and Foam Cell Formation.
Zhang X; Li J; Luo S; Wang M; Huang Q; Deng Z; de Febbo C; Daoui A; Liew PX; Sukhova GK; Metso J; Jauhiainen M; Shi GP; Guo J
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):597-610. PubMed ID: 31996021
[TBL] [Abstract][Full Text] [Related]
31. Regulation of lipoprotein lipase secretion in murine macrophages during foam cell formation in vitro. Effect of triglyceride-rich lipoproteins.
Sofer O; Fainaru M; Schafer Z; Goldman R
Arterioscler Thromb; 1992 Dec; 12(12):1458-66. PubMed ID: 1450177
[TBL] [Abstract][Full Text] [Related]
32. Simvastatin inhibited oxLDL-induced proatherogenic effects through calpain-1-PPARγ-CD36 pathway.
Yang X; Yin M; Yu L; Lu M; Wang H; Tang F; Zhang Y
Can J Physiol Pharmacol; 2016 Dec; 94(12):1336-1343. PubMed ID: 27733051
[TBL] [Abstract][Full Text] [Related]
33. Tissue-specific postprandial clearance is the major determinant of PPARgamma-induced triglyceride lowering in the rat.
Laplante M; Festuccia WT; Soucy G; Blanchard PG; Renaud A; Berger JP; Olivecrona G; Deshaies Y
Am J Physiol Regul Integr Comp Physiol; 2009 Jan; 296(1):R57-66. PubMed ID: 18971352
[TBL] [Abstract][Full Text] [Related]
34. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties.
Bouhlel MA; Derudas B; Rigamonti E; Dièvart R; Brozek J; Haulon S; Zawadzki C; Jude B; Torpier G; Marx N; Staels B; Chinetti-Gbaguidi G
Cell Metab; 2007 Aug; 6(2):137-43. PubMed ID: 17681149
[TBL] [Abstract][Full Text] [Related]
35. The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages.
Fu Y; Luo N; Lopes-Virella MF; Garvey WT
Atherosclerosis; 2002 Dec; 165(2):259-69. PubMed ID: 12417276
[TBL] [Abstract][Full Text] [Related]
36. Curcuma oil attenuates accelerated atherosclerosis and macrophage foam-cell formation by modulating genes involved in plaque stability, lipid homeostasis and inflammation.
Singh V; Rana M; Jain M; Singh N; Naqvi A; Malasoni R; Dwivedi AK; Dikshit M; Barthwal MK
Br J Nutr; 2015 Jan; 113(1):100-13. PubMed ID: 25391643
[TBL] [Abstract][Full Text] [Related]
37. PPARalpha, but not PPARgamma, activators decrease macrophage-laden atherosclerotic lesions in a nondiabetic mouse model of mixed dyslipidemia.
Hennuyer N; Tailleux A; Torpier G; Mezdour H; Fruchart JC; Staels B; Fiévet C
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1897-902. PubMed ID: 15994444
[TBL] [Abstract][Full Text] [Related]
38. Fatty Acid-Binding Protein 4 mediates apoptosis via endoplasmic reticulum stress in mesangial cells of diabetic nephropathy.
Yao F; Li Z; Ehara T; Yang L; Wang D; Feng L; Zhang Y; Wang K; Shi Y; Duan H; Zhang L
Mol Cell Endocrinol; 2015 Aug; 411():232-42. PubMed ID: 25958041
[TBL] [Abstract][Full Text] [Related]
39. A FABP4-PPARγ signaling axis regulates human monocyte responses to electrophilic fatty acid nitroalkenes.
Lamas Bervejillo M; Bonanata J; Franchini GR; Richeri A; Marqués JM; Freeman BA; Schopfer FJ; Coitiño EL; Córsico B; Rubbo H; Ferreira AM
Redox Biol; 2020 Jan; 29():101376. PubMed ID: 31926616
[TBL] [Abstract][Full Text] [Related]
40. Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipase.
Ziouzenkova O; Perrey S; Asatryan L; Hwang J; MacNaul KL; Moller DE; Rader DJ; Sevanian A; Zechner R; Hoefler G; Plutzky J
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2730-5. PubMed ID: 12606719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
